학술논문
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
Document Type
Article
Author
Inzucchi, Silvio E ; Claggett, Brian L; Vaduganathan, Muthiah; Desai, Akshay S; Jhund, Pardeep S; de Boer, Rudolf A; Hernandez, Adrian F; Kosiborod, Mikhail N; Lam, Carolyn S P; Martinez, Felipe; Shah, Sanjiv J; Verma, Subodh; Han, Yaling; Kerr Saraiva, Jose F; Bengtsson, Olof; Petersson, Magnus; Langkilde, Anna Maria; McMurray, John J V; Solomon, Scott D
Source
In The Lancet Diabetes & Endocrinology December 2022 10(12):869-881
Subject
Language
ISSN
2213-8587